Complications of MI Flashcards
How does cardiac arrest arise due to MI?
- Most commonly occurs due to patients developing ventricular fibrillation
- Most common cause of death following a MI
- Patients are managed as per the ALS protocol with defibrillation.
How does cardiogenic shock arise due to MI?
- If a large part of the ventricular myocardium is damaged the ejection fraction of the heart may decrease ==> cardiogenic shock
- Difficult to treat.
- Other causes of cardiogenic shock include the ‘mechanical’ complications such as left ventricular free wall rupture
- Patients may require inotropic support and/or an intra-aortic balloon pump.
How does CHF arise from MI?
- If the patient survives the acute phase their ventricular myocardium may be dysfunctional resulting in CHF
How do tachyarrhythmias arise due to MI?
- Ventricular fibrillation is the most common cause of death following a MI
- Other common arrhythmias including ventricular tachycardia
How do bradyarrhythmias arise due to MI?
Atrioventricular block is more common following inferior myocardial infarctions
How does pericarditis arise from MI?
- Pericarditis in the first 48 hours following a transmural MI is common (c. 10% of patients).
-
Dressler’s syndrome tends to occur around 2-6 weeks following a MI:
- Autoimmune reaction against antigenic proteins formed as the myocardium recovers
- Combination of fever, pleuritic pain, pericardial effusion and a raised ESR.
- Treated with NSAIDs.
How does a left ventricular aneurysm occur?
- The ischaemic damage sustained may weaken the myocardium resulting in aneurysm formation
- Associated with persistent ST elevation and left ventricular failure
- Thrombus may form within the aneurysm increasing the risk of stroke
- Patients are therefore anticoagulated.
How does left ventricular free wall rupture arise due to MI?
- Seen in around 3% of MIs and occurs around 1-2 weeks afterwards
- Patients present with AHF secondary to cardiac tamponade (raised JVP, pulsus paradoxus, diminished heart sounds)
- Urgent pericardiocentesis and thoracotomy are required
How does ventricular septal defect occur due to MI?
- Rupture of the interventricular septum usually occurs in the first week and is seen in around 1-2% of patients
- Features: acute heart failure associated with a pan-systolic murmur
- An ECHO is diagnostic and will exclude acute mitral regurgitation which presents in a similar fashio
- Urgent surgical correction is needed.
How does acute mitral regurgitation occur due to MI?
- More common with infero-posterior infarction and may be due to ischaemia or rupture of the papillary muscle
- Features: Acute hypotension and pulmonary oedema
- An early-to-mid systolic murmur is typically heard
- Treated with vasodilator therapy but often require emergency surgical repair
What drugs should patients be offered after an MI?
- Dual antiplatelet therapy (aspirin plus a second antiplatelet agent)
- ACE inhibitor
- Beta-blocker
- Statin
What is the lifestyle advice given to patients following an MI?
- Diet: advise a Mediterranean style diet, switch butter and cheese for plant oil based products. Do not recommend omega-3 supplements or eating oily fish
- Exercise: advise 20-30 mins a day until patients are ‘slightly breathless’
- Sexual activity may resume 4 weeks after an uncomplicated MI.
- Reassure patients that sex does not increase their likelihood of a further MI. PDE5 inhibitors (e.g, sildenafil) may be used 6 months after a MI.
- They should however be avoided in patient prescribed either nitrates or nicorandil
When are aldosterone antagonists used post-STEMI?
- Patients who have had an acute MI and who have symptoms and/or signs of:
- heart failure
- Left ventricular systolic dysfunction
- Treatment with an aldosterone antagonist licensed for post-MI treatment (e.g. eplerenone) should be initiated within 3-14 days of the MI, preferably after ACE inhibitor therapy
When are patients thrombolysed in STEMI?
- Primary percutaneous coronary intervention (PCI) has emerged as the gold-standard treatment for STEMI but is not available in all centres
- Thrombolysis should be performed in patients without access to primary PCI.
What thrombolytic agents should be used in STEMI patients?
- Tissue plasminogen activator (tPA) has been shown to offer clear mortality benefits over streptokinase
- Yenecteplase is easier to administer and has been shown to have non-inferior efficacy to alteplase with a similar adverse effect profile